New Jersey AR 116: Urges FDA to make naloxone available over the counter.

Status: Introduced in the Assembly, Referred to Assembly Health and Senior Services Committee (as of 2018-02-08)

State: New Jersey · Session: 218 · Bill: AR 116

Subjects: DRUG ABUSE, PHARMACEUTIC

Sponsors: Conaway, Herb, Karabinchak, Robert J., Vainieri Huttle, Valerie

View New Jersey AR 116 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.